Imricor Medical Systems, Inc. (ASX: IMR)
Australia flag Australia · Delayed Price · Currency is AUD
1.025
+0.070 (7.33%)
Dec 20, 2024, 4:10 PM AEST

Imricor Medical Systems Company Description

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States.

The company’s principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator.

Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning.

It also performs contract research, as well as licenses its intellectual property for use in implantable devices.

Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

Imricor Medical Systems, Inc.
Imricor Medical Systems logo
Country United States
Founded 2006
Industry Medical Devices
Sector Healthcare
CEO Steven Wedan

Contact Details

Address:
400 Gateway Boulevard
Burnsville, Delaware 55337
United States
Phone 952 818 8400
Website imricor.com

Stock Details

Ticker Symbol IMR
Exchange Australian Securities Exchange
Fiscal Year January - December
Reporting Currency USD
ISIN Number AU0000054942
SIC Code 3845

Key Executives

Name Position
Steven Wedan President, Chief Executive Officer and Executive Chairman
Jonathon Gut Chief Financial Officer and Vice President of Finance
Gregg Stenzel Chief Operating Officer
Greg Englehardt Vice President of Global Sales
Nick Twohy Vice President of Marketing and Business Development
Kobe Lizheng Company Secretary and Local Agent